BURLINGTON, Mass., Dec. 11 /PRNewswire/ --
Palomar Medical Technologies Inc (Nasdaq: PMTI) today announced that Joseph P.
Caruso has been elected to Palomar's Board of Directors at a recent meeting of
the Board of Directors.
(Photo: http://www.newscom.com/cgi-bin/prnh/20000308/PMTILOGO )
Mr. Caruso is Palomar's President and Chief Operating Officer. Mr. Caruso
joined the Company in March 1992 as one of the founding members of the
management team and has served as its Vice President and Chief Financial
Officer since January 1, 1993 before being elected as President and Chief
Operating Officer on May 16, 2001. Mr. Caruso is responsible for all of the
operations of the company, including research, development, manufacturing,
service and sales. Mr. Caruso was also strategically involved in
restructuring the Company over the past few years. Prior to joining Palomar,
Mr. Caruso held various financial positions in private industry.
Louis P. (Dan) Valente, chairman and chief executive officer of Palomar,
commented "I am pleased to welcome Joe as the newest member of the Board of
Directors. The Board of Directors has recognized Joe's tremendous
contribution in the dramatic turnaround at Palomar and his ability to run all
of the operations of the company. Joe's strong background in business and
extensive knowledge of this industry makes him immensely qualified for his new
responsibilities. Joe has been instrumental in the turnaround of this company
and has been a leading contributor in developing the focus and direction of
Palomar over the past few years. He is a well known and respected member of
the cosmetic laser industry."
Mr. Caruso commented "I am honored to be elected to the Board of
Directors. We are positioned to become a powerful force in and focused on
capturing a significant share of the cosmetic laser/light-based market. Our
innovative product line currently consists of the Palomar SLP1000(TM) super
long-pulse diode laser system for hair removal and vascular treatments and our
newly introduced Palomar EsteLux(TM) light-based system for hair removal and
Palomar Q-YAG 5(TM) laser system for tattoo and pigmented lesion removal."
Caruso continued "I believe that our investment in new products research in
areas like advanced hair removal systems, fat reduction, acne treatment and
skin rejuvenation will allow us to maintain our technology leadership
position."
About Palomar Medical Technologies Inc: Palomar is a leading researcher
and developer of proprietary laser/light based systems for hair removal and
other cosmetic treatments and is the first company to obtain clearance from
the FDA for "permanent hair reduction." Palomar hair removal systems have
been installed in physician practices worldwide, and hundreds of thousands of
treatments have been performed. New and exciting indications are being tested
to further advance the hair removal market and other cosmetic applications
including fat reduction, acne treatment and skin rejuvenation.
To get more information regarding Palomar and its products, please visit
Palomar's web site at http://www.palmed.com. Also, to continue to receive the most
up-to-date information and latest news on Palomar as it happens, sign up to
receive automatic e-mail alerts by going to the e-mail alerts page in the
Investor Relations' section of the web site.
With the exception of the historical information contained in this
release, the matters described herein contain forward-looking statements,
including but not limited to statements relating to new markets, development
and introduction of new products, and financial projections that involve risk
and uncertainties that may individually or mutually impact the matters herein,
and cause actual results, events and performance to differ materially from
such forward-looking statements. These risk factors include, but are not
limited to, results of future operations, technological difficulties in
developing or introducing new products, the results of future research, lack
of product demand and market acceptance for current and future products, the
effect of economic conditions, the impact of competitive products and pricing,
governmental regulations with respect to medical devices, including whether
FDA clearance will be obtained for future products, the results of litigation,
potential infringement of third-party intellectual property rights, and/or
other factors, which are detailed from time to time in the company's SEC
reports, including the report on Form 10-K for the year ended December 31,
2000 and the Company's quarterly reports on Form 10-Q. Readers are cautioned
not to place undue reliance on these forward-looking statements, which speak
only as of the date hereof. The company undertakes no obligation to release
publicly the result of any revisions to these forward-looking statements that
may be made to reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
Contact: Paul S. Weiner
Treasurer
Palomar Medical Technologies, Inc.
781-993-2411
ir@palmed.com
SOURCE Palomar Medical Technologies Inc
 back to top
Related links:
http://www.palmed.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20000308/PMTILOGO
PRN Photo Desk, 888-776-6555 or 212-782-2840
Company News On-Call:
http://www.prnewswire.com/comp/107555.html
CONTACT:
Paul S. Weiner, Treasurer of Palomar Medical
Technologies, Inc., +1-781-993-2411, ir@palmed.com
|
